MHP
MIRO

Manatuck Hill Partners’s Miromatrix Medical Inc. Common Stock MIRO Stock Holding History

Manatuck Hill Partners’s Portfolio MIRO Stock Details MIRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-83,042
Closed -$578K – 143
2021
Q3 		$578K Sell
83,042
-16,958
-17% -$160K 0.2% 80
2021
Q2 		$1.17M Buy
+100,000
New +$1.29M 0.35% 63

Other funds holding MIRO

GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
FA
Friess Associates Greenville, Delaware $59.9M AUM 3.42% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Manatuck Hill Partners's MIRO Position: Q4 2021 in Review

Manatuck Hill Partners sold out of Miromatrix Medical Inc. Common Stock (MIRO) in Q4 2021, closing a stake of 83,042 shares — an estimated $578K sold.

Manatuck Hill Partners first reported a position in MIRO in Q2 2021 and held it in 2 quarters. The position peaked at $1.17M in Q2 2021. 22 funds tracked by Wall St. Rank hold MIRO as of Q4 2021.

  • Manatuck Hill Partners reported no remaining Miromatrix Medical Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Manatuck Hill Partners sold 83,042 Miromatrix Medical Inc. Common Stock shares in Q4 2021, an estimated $578K.
  • Manatuck Hill Partners first reported a position in Miromatrix Medical Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Manatuck Hill Partners's Miromatrix Medical Inc. Common Stock position peaked at $1.17M in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Miromatrix Medical Inc. Common Stock as of Q4 2021.

Based on Manatuck Hill Partners's 13F filing for Q4 2021, filed 14 Feb 2022.